Cover
Vol. 8 No. 2 (2018)

Published: December 31, 2018

Pages: 14-20

Research Article

Male Fertility Supplements (MFS Plus) Treatment Improve Se­ men Quality in a Sample of Iraqi Infertile Males

Haider M. M.Dabbach 1 Majid H. Ahmed 2
1Al-Imamain Al-Kadhimain Medical City,Baghdad-IRAQ
2College of Medicine, Al-Nahrain University, Baghdad, IRAQ
History
  • Received: September 1, 2018
  • Available Online: December 1, 2018
DOI

https://doi.org/10.28969/IJEIR.v8.i2.r3

Abstract

Background : At least in 25% of infertile men, no identifiable cause can be at­ tributed to the problem,so it is termed idiopathic infertility. Those men are candi­ dates for empiric medical therapy which include antioxidant therapy. Men upple­ ment Plus (MFS Plus) uses a powerful all-natural formula of many antioxidants in addition to Relora to improve semen quality. Objectives: To evaluate the effect of MFS Plus on sperms concentration, motility and morphology in men with oligo and/or asthenozoopermia in sample of Iraqi infertile males. Methods: Acomparative clinical trial study was conducted at High Institute of Infertility Diagnosis and Assisted Reproductive Technologies during the period from July 2015 till February 2017. Male partner of infertile couples who had one or more of the following criteria oligo, astheno, and/or teratozospermia accord­ ing to criteria of WHO 2010 were involved in this study. Eighty-one males were divided randomly into two groups, the first group (group A) were given MFS Plus capsule AMS® (America Medic & Science) two cap­ sules twice daily for three months and the second group (group B) were given vitamin E capsule (one capsule three times daily) for the same period.A second semen analysis were done after three months for each subject in both groups to show the effect of both types of treatment on semen quality. Results: There was a highly significant increase in sperms progressive motility % (14.0±11.41 vs 29.35±15.61, p value < 0.001) and a highly significant decrease in immotile sperms % (60.15±19.3 vs 41.52±18.18, p value < 0.001) in the group of patients who received MFS Plus treatment. Moreover, there was significant increase in sperm concentration and percentage of normal sperm morphology (p value = 0.027, 0.019 respectively). However, no significant change was observed regarding semen volume and percentage of non-progressive motility.Whereas there were no significant changes in any of semen analysis parameters in the group of patients (group B) who received placebo. Conclusion: MFS Plus usage for three months is very beneficial for sperm motil­ ity in addition to its valuable effect on sperm concentration and morphology and it is more efficient than vitamin E alone.

Keywords

References

  1. AgarwalA, MulgundA, HamadaA, Chy­ atteMR. A unique view on male infertility around the globe. ReprodBiolEndocrinol. 2015; 13: 37. doi: 10.1186/s12958-015- 0032-1.
  2. Poch MA, Sigman M. Clinical evalua­ tion and treatment of male factor infer­ tility. In: Carrell DT and Peterson CM. (eds). Reproductive endocrinology and infertility - Integrating modern clini­ cal and laboratory practice. 1st ed. New York. Springer. 2010; 367-378.
  3. Carter JN, Tyson JE, Tolis G, Van Vliet S, Faiman C, Friesen HG. Pro­ lactin-screening tumors and hypo­ gonadism in 22 men. N Engl J Med. 1978; 299(16): 847-52. DOI: 10.1056/ NEJM197810192991602.
  4. Hopps CV, Mielnik A, Goldstein M, Palermo GD, Rosenwaks Z, Schlegel PN. Detection of sperm in men with Y chro­ mosome microdeletions of the AZFa, AZFb and AZFc regions. Hum Reprod. 2003; 18(8): 1660-1665.
  5. Matsuda T, Horii Y, Yoshida O. Ob­ structive azoospermia of unknown or­ igin: sites of obstruction and surgical outcomes. J Urol. 1994; 151(6): 1543- 1546.
  6. Turek PJ. Male infertility. In Tanagho EA, McAninch JW. Smith’s General Urol­ ogy 17thed. New York: McGraw-Hill; 2008. P. 712.
  7. Eliasson R. Semen analysis with regard to sperm number, sperm morphology and functional aspects. Asian J Androl, 2010; 12: 26-32.
  8. Baker HW, Brindle J, Irvine DS, Aitken RJ. Protective effect of antioxidant on the impairment of semen motility by activat­ ed polymorphonuclear leukocyte. Fertil­ Steril. 1996; 65(2): 411-419.
  9. World Health Organization. WHO Lab­ oratory Manual for the Examination and Processing of Human Semen. Geneva: WHO Press. 2010. Iraqi Journal Of Embryos and Infertility Researches Vol.(8) Issue (2) (2018) IJEIR ISSN: 2616-6984
  10. Radigue C, Es-Slami S, Soufir J. Relationship of carnitine transport across the epididymis to blood carni­ tine and androgens in rats. Arch An­ drol. 1996; 37: 27-31.
  11. Sigman M, Glass S, Campagnone J, Pryor JL. Carnitine for the treatment of idiopathic asthenospermia: a ran­ domized, double-blind, placebo-con­ trolled trial. FertilSteril. 2006; 85: 1409-1414.
  12. Lenzi A, Sgro P, Salacone P, Paoli D, Gilio B, Lombardo F, et al. A place­ bo-controlled doubleblind randomized trial of the use of combined l-carnitine and l-acetyl-carnitine treatment in men with asthenozoospermia. FertilSteril 2004; 81: 1578-1584.
  13. Akmal M, Qadri JQ, Al-Waili NS, Thangal S, Haq A, Saloom KY. Im­ provement in human semen quality af­ ter oral supplementation of vitamin C. J Med Food. 2006; 9(3): 440-442.
  14. Ebisch I, Pierik F, De Jong F, Thom­ as C,Steegers‐Theunissen R. Does fo­ lic acid and zinc sulphate intervention affect endocrine parameters and sperm characteristics in men? Int J Androl. 2006; 29: 339-345.
  15. Safarinejad MR, Safarinejad S. Effi­ cacy of selenium and/or N-acetyl-cys­ teine for improving semen parameters in infertile men: a double-blind, pla­ cebo controlled, randomized study. J Urol. 2009 Feb;181(2):741-51. doi: 10.1016/j.juro.2008.10.015.
  16. Moslemi MK, Tavanbakhsh S. Se­ lenium-vitamin E supplementation in infertile men: effects on semen pa­ rameters and pregnancy rate. Int J Gen Med. 2011; 4: 99-104.
  17. Lafuente R, González-Comadrán M, Solà I, López G, Brassesco M, Car­ reras R, et al. Coenzyme Q10 and male infertility: a meta-analysis. J AssisRe­ prod Gen 2013; 30: 1147-1156.
  18. ZhaoJ, DongX, Hu X, Long Z, Wang L, Liu Q, Sun B, Wang Q, Wu Q, Iraqi Journal Of Embryos and Infertility Researches Vol.(8) Issue (2) (2018) and Lia L.Zinc levels in seminal plas­ ma and their correlation with male in­ fertility: A systematic review and me­ ta-analysis. Sci Rep. 2016; 6: 22386. doi: 10.1038/srep22386.
  19. Yamamoto Y, Aizawa K, Mieno M, Karamatsu M, Hirano Y, Furui K, Miyashita T, Yamazaki K, Inaku­ ma T, Sato I, Suganuma H, Iwamo­ to T. The effects of tomato juice on male infertility. Asia Pac J ClinNutr. 2017; 26(1): 65-71. doi: 10.6133/ap­ jcn.102015.17.
  20. Ross C, Morriss A, Khairy M, Khalaf Y, Braude P, Coomarasamy A, et al. A systematic review of the effect of oral antioxidants on male infertility. Reprod Biomed Online 2010; 20: 711- 723.
  21. MurphyL E, MillsJL, MolloyAM, Qian C, CarterTC, StrevensH, Wide-Swensson D, Giwercman A, Levine RJ. Folate and vitamin B12 in idiopathic male infertility.